Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trental 400 is indicated in the treatment of peripheral vascular disease, including intermittent claudication and rest pain.
The recommended initial dose is 1 tablet (400 mg) three times daily; two tablets daily may prove sufficient in some patients, particularly for maintenance therapy. Tablets should be taken with or immediately after meals, and swallowed whole with plenty of water.
No special dosage requirements.
Trental 400 is not suitable for use in children.
In patients with impairment of renal function (creatinine clearance below 30ml/min) a dose reduction by approximately 30% to 50% may be necessary guided by individual tolerance.
The treatment of overdosage should be symptomatic with particular attention to supporting the cardiovascular system.
36 months.
Do not store above 25°C. Store in the original package.
Amber glass bottle: 100 or 250 tablets.
Plastic (PE) pots: 100 or 250 tablets.
Blister Pack (Alu/PVC): 10 or 90 tablets.
None.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
